stockportfolio.pro logostockportfolio.pro
Stocks Screener Start 7-day free trial
Stocks / HAE / Total Debt

Haemonetics Corporation Total Debt 2009–2026

Haemonetics Corporation (HAE) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings.

Fiscal yearTotal DebtChange (YoY)
FY 2026$1.24B+1.2%
FY 2025$1.22B+53.6%
FY 2024$797.56M+5.8%
FY 2023$754.10M+34.8%
FY 2022$559.44M-19.0%
FY 2021$690.59M+126.0%
FY 2020$305.51M-5.3%
FY 2019$322.45M+442.6%
FY 2018$59.42M-81.2%
FY 2017$315.81M-22.7%
FY 2016$408.46M-5.1%
FY 2015$430.48M-2.2%
FY 2014$440.29M-9.3%
FY 2013$485.69M+12779.7%
FY 2012$3.77M-22.7%
FY 2011$4.88M+9.4%
FY 2010$4.46M
FY 2009$0

Source: Haemonetics Corporation SEC filings — balance sheet (10-K). Refreshed nightly.

See the full picture for Haemonetics Corporation

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Haemonetics Corporation — frequently asked questions

What is Haemonetics Corporation's total debt (short- plus long-term borrowings)?

Haemonetics Corporation (HAE) reported total debt (short- plus long-term borrowings) of $1.24B for fiscal year 2026, per its SEC filings.

Where does this data come from?

Figures are computed from Haemonetics Corporation's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.

More HAE financial history

Full HAE fundamentals page → · All 1,500+ companies →